Skip to content

Mithridate

Active Private limited companyfounded 2023active for 3 yearsBosdel 54, 3600 GenkKBO/BCE: BE 0802.360.343

Lifetime

2 annual accounts with figures on one time axis
peak of €51,892 in 2025
€51,892▲ €82,759
lowest -€181,061 in 2024
-€139,695▲ €41,366
peak of -€175,061 in 2024
-€314,757▼ €139,695
€478,970▲ 71.3%
Board4 names since 2023
2 directors and 1 other
Documentsfilings and deeds
30-09-202661 days late
2025micro format
Gross margin from -€30,867 to €51,892Loss of €139,695Equity from -€175,061 to -€314,757Debts from €279,629 to €478,970Cash from €23,486 to €11,860

Key points

from the 2025 annual accounts

Equity

-€314,757
20242025

Debts exceed assets in financial year 2025.

Losses

-€320,757 in two years
-181,0612024-139,6952025

The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.

Debts

€478,970 292% of the balance sheet
Suppliers 3%Taxes and wages 3%Other 94%

Of this, €478,627 falls due within a year.

Board

2 joined · 2 left

2 directors joined and 2 left, the latest change on 12-11-2026. 4 are in office now.

Position in the sector

-€139,695

Lower net result than 95% of companies in wholesale trade. The sector median is €5,117, over 15,511 companies.

2025 accounts filed 61 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 7,656 companies had the same profile as Mithridate has now. Each dot stands for 20 companies, two years later.

84.7%
were still trading
5.8%
stopped another way
8.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 0.7% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,656 companies, not a prediction for Mithridate. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Director
Director
Director
  • deed of 12-11-2026
  • deed of 12-11-2026
Board & ownership

Recent changes

resigns as director acts as permanent representative · holds 1,200 shares · Discharge granted to · General meeting of 09-11-2026 · Gazette deed
3 directors appointed, 2 resignations, 1 reappointment and resign · , and appointed · reappointed · General meeting of 19-10-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0802360343
Publication in the Belgian Official Gazette Gazette deed
All 8 events

Comparable companies

same main activity, similar in size and age
Company
Mithridate Genk €164,214 €51,892 -191.7% -
PharmSync Antwerp €136,689 €75,547 76.5% -
EH Supply and Consulting Watermael-Boitsfort €117,173 €55,217 27.5% -
Cedia Lier €98,736 €53,273 25.5% -
Pamir Genk €209,336 €21,230 8.3% -
Belgomed Hasselt €184,456 €59,645 40.2% -
LIMACOM PHARMA Diepenbeek €160,632 €37,978 28.7% -

These companies have the same main activity as Mithridate: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €98,700 and €209,000, founded between 2022 and 2025.

Official details

Source: KBO
Status
Active since 02-06-2023Normal situation
Registered office
45 active companies are registered at this addressOf these, 4 started in the 12 months before 20 November 2026. Source: KBO register, as of 20 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
Establishment unit
2.346.317.4593600 Genk, since 02-06-2023
Financial year end
31 December
Peppol
Reachable since 02-10-2025
Company details

Annual accounts 2025

≈ €210,000estimated
€164,214▲ 57.0%
≈ 1.9 FTEestimated
Filing
Filed on 30-09-2026
Financials

Insights on Mithridate

The 2025 annual accounts show negative equity of -€314,757 and a net result of -€139,695. Its solvency ranks better than 7% of 15,514 sector peers (NACE 46) in financial year 2025.

The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Mithridate

What is the company number of Mithridate?
The company number of Mithridate is 0802.360.343. The VAT number is the same number with BE in front: BE 0802.360.343.
Where is Mithridate based?
The registered office is at Bosdel 54, 3600 Genk.Company details
What does Mithridate do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Mithridate?
Mithridate is a private limited company (BV).
When was Mithridate founded?
Mithridate was founded on 02-06-2023.
Is Mithridate still active?
Yes, Mithridate is an active enterprise in the KBO register.
How many employees does Mithridate have?
Mithridate had an average of 2.2 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of Mithridate?
The turnover in financial year 2025 is about €210,000. This figure is estimated from the gross margin of €51,892 and 32 comparable companies (NACE 464). It probably lies between €110,000 and €280,000.
Is Mithridate profitable?
In financial year 2025, Mithridate made a loss of €139,695.
Where can I find the annual accounts of Mithridate?
Mithridate filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Mithridate due?
Mithridate must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.